首页 > 最新文献

Arab Journal of Gastroenterology最新文献

英文 中文
Detection of early hidden carcinoma of cardia by reversely entering the esophagus with magnetically controlled capsule endoscopy: A case report. 通过磁控胶囊内窥镜反向进入食管发现早期隐性贲门癌:病例报告。
IF 1.1 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-16 DOI: 10.1016/j.ajg.2024.07.009
Lu-Jie Chang, Hai-Yan Liu, Xing-Bin Ma, Tao Gao, Cheng-Xia Liu

Magnetically controlled capsule endoscopy (MCE) is a non-invasive method for gastropathy examination. However, due to the influence of gravity and lumen structure, the traditional capsule endoscopy rapidly passes through the cardia, leading to insufficient observation of the cardia mucosa. Case Summary. The patient, a 53-year-old male, had a history of subarachnoid hemorrhage for 5 years, and it has been 5 years since the aneurysm embolization.Computed Tomography Angiography (CTA) indicated the presence of an anterior cruciate aneurysm. Given the risks associated with traditional intubated gastroscopy, magnetic controlled capsule gastroscopy was chosen for gastric examination. Following the standard operating procedure, routine magnetic controlled capsule endoscopy was performed, and no lesions were detected.We combined magnetic force and patient posture adjustment to guide the capsule to pass through the cardia slowly and return to the esophagus, successfully detecting a concealed cardia lesion.Afterwards, the lesions of the cardia were treated with a magnifying gastroscope and endoscopic submucosal dissection (ESD).Pathological findings showed that adenocarcinoma was confined to the mucosa membrane, and in the postoperative pathological study, no tumor remnants or metastasis were discovered. This paper reports a case of a patient undergoing a physical examination, but no lesion was found during a routine examination using the magnetically controlled capsule gastroscope. However, we discovered a case of hidden early cardia cancer after guiding the capsule gastroscope back into the esophagus under magnetic control.

磁控胶囊内镜(MCE)是一种无创的胃病检查方法。然而,由于重力和管腔结构的影响,传统的胶囊内镜会迅速穿过贲门,导致对贲门粘膜的观察不充分。病例摘要。患者男性,53 岁,蛛网膜下腔出血病史 5 年,动脉瘤栓塞术已过去 5 年。计算机断层扫描血管造影术(CTA)显示存在前交叉动脉瘤。考虑到传统插管胃镜检查的风险,患者选择了磁控胶囊胃镜进行胃部检查。我们将磁力和患者体位调整相结合,引导胶囊缓慢通过贲门并返回食管,成功发现了一处隐蔽的贲门病变。病理结果显示,腺癌局限于粘膜,术后病理检查未发现肿瘤残余或转移。本文报告了一例接受体检的患者,在使用磁控胶囊胃镜进行常规检查时未发现病变。然而,在磁控引导胶囊胃镜返回食管后,我们发现了一例隐藏的早期贲门癌。
{"title":"Detection of early hidden carcinoma of cardia by reversely entering the esophagus with magnetically controlled capsule endoscopy: A case report.","authors":"Lu-Jie Chang, Hai-Yan Liu, Xing-Bin Ma, Tao Gao, Cheng-Xia Liu","doi":"10.1016/j.ajg.2024.07.009","DOIUrl":"https://doi.org/10.1016/j.ajg.2024.07.009","url":null,"abstract":"<p><p>Magnetically controlled capsule endoscopy (MCE) is a non-invasive method for gastropathy examination. However, due to the influence of gravity and lumen structure, the traditional capsule endoscopy rapidly passes through the cardia, leading to insufficient observation of the cardia mucosa. Case Summary. The patient, a 53-year-old male, had a history of subarachnoid hemorrhage for 5 years, and it has been 5 years since the aneurysm embolization.Computed Tomography Angiography (CTA) indicated the presence of an anterior cruciate aneurysm. Given the risks associated with traditional intubated gastroscopy, magnetic controlled capsule gastroscopy was chosen for gastric examination. Following the standard operating procedure, routine magnetic controlled capsule endoscopy was performed, and no lesions were detected.We combined magnetic force and patient posture adjustment to guide the capsule to pass through the cardia slowly and return to the esophagus, successfully detecting a concealed cardia lesion.Afterwards, the lesions of the cardia were treated with a magnifying gastroscope and endoscopic submucosal dissection (ESD).Pathological findings showed that adenocarcinoma was confined to the mucosa membrane, and in the postoperative pathological study, no tumor remnants or metastasis were discovered. This paper reports a case of a patient undergoing a physical examination, but no lesion was found during a routine examination using the magnetically controlled capsule gastroscope. However, we discovered a case of hidden early cardia cancer after guiding the capsule gastroscope back into the esophagus under magnetic control.</p>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142299015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High frequency of anti-Saccharomyces cerevisiae antibodies in chronic hepatitis C. 慢性丙型肝炎患者体内抗酵母菌抗体的高频率。
IF 1.1 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-16 DOI: 10.1016/j.ajg.2024.07.013
Mariam Ghozzi, Amani Mankai, Fatma Mechi, Zeineb Ben Chedly, Ouafa Kallala, Sarra Melayah, Abdelhalim Trabelsi, Ibtissem Ghedira

Background and study aim: Chronic hepatitis C (CHC) is a liver disease caused by the hepatitis C virus. Anti-Saccharomyces cerevisiae (S. cerevisiae) antibodies (ASCA) are frequently reported in autoimmune diseases but rarely in viral infections. We aimed to determine the frequency of ASCA in adult patients with CHC.

Patients and methods: Eighty-eight patients with CHC and 160 healthy blood donors were included in this study. ASCA-IgG and IgA levels were determined using enzyme linked immunosorbent assay. For statistical analysis, we used open EPI version 3 as software. Correlations were determined by Spearman's test using IBM® SPSS® Statistics.

Results: ASCA (IgG or IgA) were present in 31.8 % of patients and in 3.7 % of controls (p < 10-6). ASCA-IgG and ASCA-IgA were more frequent in patients with CHC than in healthy subjects (23.9 % vs. 3.1 %; p < 10-5 and 9.1 % vs. 0.6 %; p = 0.002, respectively). In patients, mean levels of ASCA-IgG and IgA were significantly higher than in controls (9.95 ± 11.78 U/mL vs. 2.28 ± 2.86 U/mL, p < 10-6 and 5.96 ± 7.69 U/mL vs. 0.56 ± 0.12 U/mL, p < 10-6; respectively). In patients with CHC, the mean level of ASCA-IgG was significantly higher than that of ASCA-IgA (9.95 ± 11.78 U/mL vs. 5.96 ± 7.69 U/mL, p = 0.008).

Conclusion: The frequency of ASCA was significantly higher in patients with CHC than in healthy controls.

背景和研究目的:慢性丙型肝炎(CHC)是由丙型肝炎病毒引起的肝病。抗酿酒酵母(S. cerevisiae)抗体(ASCA)经常见于自身免疫性疾病,但很少见于病毒感染。我们旨在确定CHC成年患者中ASCA的频率:本研究纳入了 88 名 CHC 患者和 160 名健康献血者。采用酶联免疫吸附试验测定ASCA-IgG和IgA水平。统计分析采用开放式 EPI 3 版软件。结果:31.8%的患者和 3.7%的对照组存在 ASCA(IgG 或 IgA)(p -6)。CHC患者中ASCA-IgG和ASCA-IgA的出现率高于健康人(分别为23.9%对3.1%;p -5和9.1%对0.6%;p = 0.002)。在患者中,ASCA-IgG 和 IgA 的平均水平显著高于对照组(分别为 9.95 ± 11.78 U U/mL vs. 2.28 ± 2.86 U U/mL, p -6 和 5.96 ± 7.69 U U/mL vs. 0.56 ± 0.12 U U/mL, p -6;)。CHC患者的ASCA-IgG平均水平显著高于ASCA-IgA(9.95 ± 11.78 U U/mL vs. 5.96 ± 7.69 U U/mL, p = 0.008):结论:CHC患者的ASCA发生率明显高于健康对照组。
{"title":"High frequency of anti-Saccharomyces cerevisiae antibodies in chronic hepatitis C.","authors":"Mariam Ghozzi, Amani Mankai, Fatma Mechi, Zeineb Ben Chedly, Ouafa Kallala, Sarra Melayah, Abdelhalim Trabelsi, Ibtissem Ghedira","doi":"10.1016/j.ajg.2024.07.013","DOIUrl":"https://doi.org/10.1016/j.ajg.2024.07.013","url":null,"abstract":"<p><strong>Background and study aim: </strong>Chronic hepatitis C (CHC) is a liver disease caused by the hepatitis C virus. Anti-Saccharomyces cerevisiae (S. cerevisiae) antibodies (ASCA) are frequently reported in autoimmune diseases but rarely in viral infections. We aimed to determine the frequency of ASCA in adult patients with CHC.</p><p><strong>Patients and methods: </strong>Eighty-eight patients with CHC and 160 healthy blood donors were included in this study. ASCA-IgG and IgA levels were determined using enzyme linked immunosorbent assay. For statistical analysis, we used open EPI version 3 as software. Correlations were determined by Spearman's test using IBM® SPSS® Statistics.</p><p><strong>Results: </strong>ASCA (IgG or IgA) were present in 31.8 % of patients and in 3.7 % of controls (p < 10<sup>-6</sup>). ASCA-IgG and ASCA-IgA were more frequent in patients with CHC than in healthy subjects (23.9 % vs. 3.1 %; p < 10<sup>-5</sup> and 9.1 % vs. 0.6 %; p = 0.002, respectively). In patients, mean levels of ASCA-IgG and IgA were significantly higher than in controls (9.95 ± 11.78 U/mL vs. 2.28 ± 2.86 U/mL, p < 10<sup>-6</sup> and 5.96 ± 7.69 U/mL vs. 0.56 ± 0.12 U/mL, p < 10<sup>-6</sup>; respectively). In patients with CHC, the mean level of ASCA-IgG was significantly higher than that of ASCA-IgA (9.95 ± 11.78 U/mL vs. 5.96 ± 7.69 U/mL, p = 0.008).</p><p><strong>Conclusion: </strong>The frequency of ASCA was significantly higher in patients with CHC than in healthy controls.</p>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142299016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CircFLNA facilitates gastric cancer cell proliferation and glycolysis via regulating SOX5 by sponging miR-1200. CircFLNA 通过海绵状 miR-1200 调节 SOX5,促进胃癌细胞增殖和糖酵解。
IF 1.1 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-14 DOI: 10.1016/j.ajg.2024.07.012
Xinxing Yang, Dongsheng Li, Yuqin Sun, Lisha Yi, Qiuxian Chen, Yadong Lai

Background and study aims: Circular RNAs (circRNAs) are important regulators for gastric cancer (GC) progression. Our study aims to investigate the role and mechanism of circFLNA in GC progression.

Patients and methods: The levels of circFLNA, microRNA (miR)-1200 and SRY-box transcription factor 5 (SOX5) were examined using qRT-PCR. Flow cytometry, cell counting kit 8 assay and EdU assay were performed to measure cell proliferation and apoptosis. Cell glycolysis ability was assessed by examining glucose uptake and lactate produce. RNA interaction was determined using RNA pull-down assay and dual-luciferase reporter assay. Mice xenograft models were constructed to evaluate the regulation of circFLNA knockdown on GC tumor growth.

Results: CircFLNA was upregulated in GC tissues. Functional experiments showed that circFLNA knockdown suppressed GC cell proliferation, inhibited glycolysis, and promoted apoptosis in vitro, as well as reduced GC tumor growth in vivo. CircFLNA sponged miR-1200, and miR-1200 targeted SOX5. MiR-1200 mimic reversed the promotion effect of circFLNA overexpression on GC cell growth and glycolysis, and SOX5 upregulation also abolished the inhibiting effect of miR-1200 mimic on GC cell growth and glycolysis.

Conclusion: Our data suggest that circFLNA might exert oncogenic role in GC development, which promoted GC proliferation and glycolysis through regulating miR-1200/SOX5 axis.

背景和研究目的:环状RNA(circRNA)是胃癌(GC)进展的重要调控因子。我们的研究旨在探讨 circFLNA 在 GC 进展中的作用和机制:使用 qRT-PCR 检测 circFLNA、microRNA (miR)-1200 和 SRY-box 转录因子 5 (SOX5) 的水平。流式细胞术、细胞计数试剂盒 8 检测法和 EdU 检测法用于测量细胞增殖和凋亡。通过检测葡萄糖摄取量和乳酸产生量评估细胞糖酵解能力。使用 RNA 拉取试验和双荧光素酶报告试验确定 RNA 相互作用。建立小鼠异种移植模型,评估circFLNA敲除对GC肿瘤生长的调控作用:结果:circFLNA在GC组织中上调。功能实验表明,体外敲除circFLNA可抑制GC细胞增殖、抑制糖酵解、促进细胞凋亡,体内敲除circFLNA可减少GC肿瘤的生长。circFLNA能疏导miR-1200,而miR-1200靶向SOX5。MiR-1200模拟物逆转了circFLNA过表达对GC细胞生长和糖酵解的促进作用,而SOX5的上调也消除了miR-1200模拟物对GC细胞生长和糖酵解的抑制作用:我们的数据表明,circFLNA可能在GC发育过程中发挥致癌作用,通过调控miR-1200/SOX5轴促进GC增殖和糖酵解。
{"title":"CircFLNA facilitates gastric cancer cell proliferation and glycolysis via regulating SOX5 by sponging miR-1200.","authors":"Xinxing Yang, Dongsheng Li, Yuqin Sun, Lisha Yi, Qiuxian Chen, Yadong Lai","doi":"10.1016/j.ajg.2024.07.012","DOIUrl":"https://doi.org/10.1016/j.ajg.2024.07.012","url":null,"abstract":"<p><strong>Background and study aims: </strong>Circular RNAs (circRNAs) are important regulators for gastric cancer (GC) progression. Our study aims to investigate the role and mechanism of circFLNA in GC progression.</p><p><strong>Patients and methods: </strong>The levels of circFLNA, microRNA (miR)-1200 and SRY-box transcription factor 5 (SOX5) were examined using qRT-PCR. Flow cytometry, cell counting kit 8 assay and EdU assay were performed to measure cell proliferation and apoptosis. Cell glycolysis ability was assessed by examining glucose uptake and lactate produce. RNA interaction was determined using RNA pull-down assay and dual-luciferase reporter assay. Mice xenograft models were constructed to evaluate the regulation of circFLNA knockdown on GC tumor growth.</p><p><strong>Results: </strong>CircFLNA was upregulated in GC tissues. Functional experiments showed that circFLNA knockdown suppressed GC cell proliferation, inhibited glycolysis, and promoted apoptosis in vitro, as well as reduced GC tumor growth in vivo. CircFLNA sponged miR-1200, and miR-1200 targeted SOX5. MiR-1200 mimic reversed the promotion effect of circFLNA overexpression on GC cell growth and glycolysis, and SOX5 upregulation also abolished the inhibiting effect of miR-1200 mimic on GC cell growth and glycolysis.</p><p><strong>Conclusion: </strong>Our data suggest that circFLNA might exert oncogenic role in GC development, which promoted GC proliferation and glycolysis through regulating miR-1200/SOX5 axis.</p>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142299014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abnormal expression of autophagy proteins in the duodenum of patients with functional dyspepsia: A preliminary study. 功能性消化不良患者十二指肠中自噬蛋白的异常表达:一项初步研究。
IF 1.1 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-14 DOI: 10.1016/j.ajg.2024.07.002
Lijun Du, Mengsha Cen, Fangli Cheng, Ning Dai

Background and study aims: Functional dyspepsia (FD) is a common disease with an unclear pathology. Autophagy is associated with inflammation and has been proposed to play a role in the development of FD. This study aimed to evaluate expression of the autophagy proteins beclin1 and p62/SQSTM1 in patients with FD.

Patients and methods: Duodenal mucosal tissues were collected from 10 patients with FD and 10 asymptomatic controls. The extent of autophagy was determined by examining expression levels of beclin1 and p62/SQSTM1 using quantitative polymerase chain reaction and immunohistochemistry techniques.

Results: Lower expression levels of beclin1 protein were detected in the duodenal bulb (D1) and the second portion of the duodenum (D2) in patients with FD compared with asymptomatic controls. Higher levels of p62 protein were expressed in D1 in patients with FD than in controls. No differences in mRNA expression of beclin1 and p62 were observed between patients with FD and controls.

Conclusion: Abnormal autophagy was involved in FD, which may be associated with the pathogenesis of FD.

背景和研究目的:功能性消化不良(FD)是一种病理不清的常见疾病。自噬与炎症有关,并被认为在功能性消化不良的发病过程中发挥作用。本研究旨在评估 FD 患者体内自噬蛋白 beclin1 和 p62/SQSTM1 的表达情况:收集了10名FD患者和10名无症状对照者的十二指肠粘膜组织。采用定量聚合酶链反应和免疫组化技术检测beclin1和p62/SQSTM1的表达水平,从而确定自噬程度:结果:与无症状对照组相比,在FD患者的十二指肠球部(D1)和十二指肠第二部分(D2)检测到的beclin1蛋白表达水平较低。与对照组相比,FD 患者 D1 中 p62 蛋白的表达水平更高。在FD患者和对照组之间未观察到beclin1和p62的mRNA表达差异:结论:自噬异常参与了FD,这可能与FD的发病机制有关。
{"title":"Abnormal expression of autophagy proteins in the duodenum of patients with functional dyspepsia: A preliminary study.","authors":"Lijun Du, Mengsha Cen, Fangli Cheng, Ning Dai","doi":"10.1016/j.ajg.2024.07.002","DOIUrl":"https://doi.org/10.1016/j.ajg.2024.07.002","url":null,"abstract":"<p><strong>Background and study aims: </strong>Functional dyspepsia (FD) is a common disease with an unclear pathology. Autophagy is associated with inflammation and has been proposed to play a role in the development of FD. This study aimed to evaluate expression of the autophagy proteins beclin1 and p62/SQSTM1 in patients with FD.</p><p><strong>Patients and methods: </strong>Duodenal mucosal tissues were collected from 10 patients with FD and 10 asymptomatic controls. The extent of autophagy was determined by examining expression levels of beclin1 and p62/SQSTM1 using quantitative polymerase chain reaction and immunohistochemistry techniques.</p><p><strong>Results: </strong>Lower expression levels of beclin1 protein were detected in the duodenal bulb (D1) and the second portion of the duodenum (D2) in patients with FD compared with asymptomatic controls. Higher levels of p62 protein were expressed in D1 in patients with FD than in controls. No differences in mRNA expression of beclin1 and p62 were observed between patients with FD and controls.</p><p><strong>Conclusion: </strong>Abnormal autophagy was involved in FD, which may be associated with the pathogenesis of FD.</p>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142299012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Introducing the Arabic inflammatory bowel disease disk as a tool for assessing disability in patients with inflammatory bowel disease in Jordan. 将阿拉伯文炎症性肠病盘作为评估约旦炎症性肠病患者残疾状况的工具。
IF 1.1 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-13 DOI: 10.1016/j.ajg.2024.01.011
Tarek Mazzawi, Ahmad Yadk, Nayef Alghneimin, Saad Hmeimat, Mohammad Saleem Al-Essa, Haneen Abed Alghafer, Farah Haneyah, Hanan Alkhawaldeh, Eid Samara, Bandar Ghazal

Background and study aim: Inflammatory bowel diseases (IBD) are chronic relapsing-remitting disorders of the gastrointestinal tract. IBD causes significant impairment in the patient's quality of life that should be assessed and monitored in a flexible and easy way. The IBD-Disability Index (IBD-DI) is the only validated tool to assess disability in IBD patients, but it is difficult to use in clinical practice. The IBD Disk is a new shortened, self-administering version of the IBD-DI that allows quick assessment of IBD patients and tracks changes in disease burden over time. However, the IBD Disk has not been used yet in clinical practice in Jordan. The aim of the study was to translate the IBD Disk to Arabic language and introduce it in clinical practice in Jordan.

Patients and methods: After translating the original IBD Disk to Arabic language, IBD patients referred to outpatient clinic or admitted to the medical department at the new Al-Hussein hospital, Al-Salt, Jordan, from September 2021 until March 2022, filled the translated IBD Disk.

Results: A total of 50 IBD patients (52 % males) were included in the study and filled the IBD Disk. The IBD Disk was easy to complete by the patients. Energy, regulating defecation, and emotions were the most disabling domains for relapsing patients. Polygonal shape area of the mean for IBD Disk scores decreased during remission. Education & work and energy had the strongest correlation at relapse.

Conclusion: The IBD Disk is a reliable visual representation of IBD disability. In this study, a translated version of IBD Disk to Arabic language was introduced for the first time in clinical practice in Jordan. The reduction in the polygonal shape area of the scores' mean represents decreased disease burden.

研究背景和目的:炎症性肠病(IBD)是一种慢性复发性胃肠道疾病。IBD 会严重影响患者的生活质量,应采用灵活简便的方法对其进行评估和监测。IBD-残疾指数(IBD-DI)是评估 IBD 患者残疾状况的唯一有效工具,但在临床实践中很难使用。IBD Disk 是 IBD-DI 的一种新的简易自测版本,可对 IBD 患者进行快速评估,并跟踪疾病负担随时间的变化。然而,约旦尚未在临床实践中使用 IBD Disk。本研究的目的是将 IBD Disk 翻译成阿拉伯语,并将其引入约旦的临床实践中:将原版 IBD Disk 翻译成阿拉伯语后,从 2021 年 9 月至 2022 年 3 月,在约旦 Al-Salt 的新 Al-Hussein 医院门诊或住院的 IBD 患者填写了翻译后的 IBD Disk:共有 50 名 IBD 患者(52% 为男性)参与研究并填写了 IBD 病历卡。患者很容易填写 IBD 盘。能量、排便调节和情绪是复发患者最不擅长的领域。在缓解期,IBD 盘平均得分的多边形面积有所减少。复发时,教育和工作与精力的相关性最强:结论:IBD 盘是 IBD 残疾的可靠视觉代表。在这项研究中,约旦首次在临床实践中引入了翻译成阿拉伯语的 IBD Disk。得分平均值多边形面积的缩小代表着疾病负担的减轻。
{"title":"Introducing the Arabic inflammatory bowel disease disk as a tool for assessing disability in patients with inflammatory bowel disease in Jordan.","authors":"Tarek Mazzawi, Ahmad Yadk, Nayef Alghneimin, Saad Hmeimat, Mohammad Saleem Al-Essa, Haneen Abed Alghafer, Farah Haneyah, Hanan Alkhawaldeh, Eid Samara, Bandar Ghazal","doi":"10.1016/j.ajg.2024.01.011","DOIUrl":"https://doi.org/10.1016/j.ajg.2024.01.011","url":null,"abstract":"<p><strong>Background and study aim: </strong>Inflammatory bowel diseases (IBD) are chronic relapsing-remitting disorders of the gastrointestinal tract. IBD causes significant impairment in the patient's quality of life that should be assessed and monitored in a flexible and easy way. The IBD-Disability Index (IBD-DI) is the only validated tool to assess disability in IBD patients, but it is difficult to use in clinical practice. The IBD Disk is a new shortened, self-administering version of the IBD-DI that allows quick assessment of IBD patients and tracks changes in disease burden over time. However, the IBD Disk has not been used yet in clinical practice in Jordan. The aim of the study was to translate the IBD Disk to Arabic language and introduce it in clinical practice in Jordan.</p><p><strong>Patients and methods: </strong>After translating the original IBD Disk to Arabic language, IBD patients referred to outpatient clinic or admitted to the medical department at the new Al-Hussein hospital, Al-Salt, Jordan, from September 2021 until March 2022, filled the translated IBD Disk.</p><p><strong>Results: </strong>A total of 50 IBD patients (52 % males) were included in the study and filled the IBD Disk. The IBD Disk was easy to complete by the patients. Energy, regulating defecation, and emotions were the most disabling domains for relapsing patients. Polygonal shape area of the mean for IBD Disk scores decreased during remission. Education & work and energy had the strongest correlation at relapse.</p><p><strong>Conclusion: </strong>The IBD Disk is a reliable visual representation of IBD disability. In this study, a translated version of IBD Disk to Arabic language was introduced for the first time in clinical practice in Jordan. The reduction in the polygonal shape area of the scores' mean represents decreased disease burden.</p>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142299018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between fibrosis-4 score and microvascular complications in patients with type 2 diabetes mellitus 2 型糖尿病患者纤维化-4 评分与微血管并发症之间的关系。
IF 1.1 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.ajg.2024.04.001

Background and study aims

Nonalcoholic fatty liver disease is the most prevalent chronic liver disease globally and is linked to augmented susceptibility to type 2 diabetes mellitus (DM), cardiovascular disease, and microvascular complications inherent to DM, such as nephropathy, neuropathy, and retinopathy. The fibrosis-4 (FIB-4) scoring system, a noninvasive tool, is useful for predicting the extent of liver fibrosis across diverse pathologies. This study aimed to assess the potential predictive role of FIB-4 scores in microvascular complications associated with diabetes.

Patients and methods

The medical records of patients with type 2 DM admitted to our endocrinology clinic between February 2019 and December 2020 were retrospectively evaluated. Parameters including demographic attributes, fasting blood glucose, glycated hemoglobin, aspartate aminotransferase, alanine aminotransferase, thrombocyte levels, and microvascular complications were recorded. The FIB-4 score was computed, and patients were categorized based on these scores (<1.3 and ≥ 1.3).

Results

The analysis included 312 patients with a median age of 60 (50–68 years); 39.7 % were men. The median duration of diabetes was 10 years (5–20 years), and the median FIB-4 score was 0.93 (0.63–1.34). Neuropathy, nephropathy, and retinopathy were observed in 50.6 %, 31.4 %, and 34 % of the patients, respectively. Although the FIB-4 score did not differ significantly between patients with and without neuropathy or retinopathy, patients with nephropathy exhibited higher FIB-4 scores. Notably, patients with FIB-4 scores ≥ 1.3 demonstrated a significantly higher prevalence of nephropathy. Logistic regression analysis demonstrated that higher FIB-4 scores were significantly associated with an increased risk of nephropathy.

Conclusion

The FIB-4 score is a cost-effective and straightforward tool with potential applicability in predicting nephropathy in individuals with type 2 DM.

背景和研究目的:非酒精性脂肪肝是全球发病率最高的慢性肝病,与2型糖尿病(DM)、心血管疾病和DM固有的微血管并发症(如肾病、神经病变和视网膜病变)的易感性增加有关。肝纤维化-4(FIB-4)评分系统是一种无创工具,可用于预测不同病理情况下的肝纤维化程度。本研究旨在评估 FIB-4 评分对糖尿病相关微血管并发症的潜在预测作用:回顾性评估了 2019 年 2 月至 2020 年 12 月期间内分泌科门诊收治的 2 型糖尿病患者的病历。记录的参数包括人口统计学属性、空腹血糖、糖化血红蛋白、天冬氨酸氨基转移酶、丙氨酸氨基转移酶、血小板水平和微血管并发症。计算 FIB-4 评分,并根据这些评分对患者进行分类(结果:分析包括 312 名患者,中位年龄为 60 岁(50-68 岁);39.7% 为男性。糖尿病病程中位数为 10 年(5-20 年),FIB-4 评分中位数为 0.93(0.63-1.34)。分别有 50.6%、31.4% 和 34% 的患者出现神经病变、肾病变和视网膜病变。虽然 FIB-4 评分在有神经病变和视网膜病变的患者与无神经病变和视网膜病变的患者之间没有显著差异,但肾病患者的 FIB-4 评分较高。值得注意的是,FIB-4 评分≥ 1.3 的患者肾病患病率明显更高。逻辑回归分析表明,FIB-4评分越高,肾病风险越大:结论:FIB-4 评分是一种成本效益高且简单易行的工具,可用于预测 2 型糖尿病患者的肾病。
{"title":"Relationship between fibrosis-4 score and microvascular complications in patients with type 2 diabetes mellitus","authors":"","doi":"10.1016/j.ajg.2024.04.001","DOIUrl":"10.1016/j.ajg.2024.04.001","url":null,"abstract":"<div><h3>Background and study aims</h3><p><span>Nonalcoholic fatty liver disease is the most prevalent </span>chronic liver disease<span><span><span> globally and is linked to augmented susceptibility to type 2 diabetes mellitus (DM), cardiovascular disease, and </span>microvascular complications<span> inherent to DM, such as nephropathy, </span></span>neuropathy<span>, and retinopathy<span>. The fibrosis-4 (FIB-4) scoring system, a noninvasive tool, is useful for predicting the extent of liver fibrosis across diverse pathologies. This study aimed to assess the potential predictive role of FIB-4 scores in microvascular complications associated with diabetes.</span></span></span></p></div><div><h3>Patients and methods</h3><p><span><span><span>The medical records of patients with type 2 DM admitted to our </span>endocrinology clinic between February 2019 and December 2020 were retrospectively evaluated. Parameters including demographic attributes, fasting </span>blood glucose<span>, glycated hemoglobin, aspartate aminotransferase, </span></span>alanine aminotransferase, thrombocyte levels, and microvascular complications were recorded. The FIB-4 score was computed, and patients were categorized based on these scores (&lt;1.3 and ≥ 1.3).</p></div><div><h3>Results</h3><p><span><span>The analysis included 312 patients with a median age of 60 (50–68 years); 39.7 % were men. The median duration of diabetes was 10 years (5–20 years), and the median FIB-4 score was 0.93 (0.63–1.34). Neuropathy, nephropathy, and retinopathy were observed in 50.6 %, 31.4 %, and 34 % of the patients, respectively. Although the FIB-4 score did not differ significantly between patients with and without </span>neuropathy or retinopathy, patients with nephropathy exhibited higher FIB-4 scores. Notably, patients with FIB-4 scores ≥ 1.3 demonstrated a significantly higher prevalence of nephropathy. </span>Logistic regression analysis demonstrated that higher FIB-4 scores were significantly associated with an increased risk of nephropathy.</p></div><div><h3>Conclusion</h3><p>The FIB-4 score is a cost-effective and straightforward tool with potential applicability in predicting nephropathy in individuals with type 2 DM.</p></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140892529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal manifestations in a cohort of pediatric patients with inflammatory bowel disease 一组儿科炎症性肠病患者的肾脏表现。
IF 1.1 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.ajg.2024.05.002

Background and study aims

Renal involvement in inflammatory bowel disease is rather uncommon. This study aims to describe the spectrum of renal involvement in pediatric patients with IBD and reduce delay in detection and management.

Patients and methods

This is a retrospective study of the renal function of all patients, aged <18 years, who have been followed for IBD in our pediatric gastroenterology department from January 2019 till January 2023.

Results

From the 75 IBD patients included in this study 16 % had renal manifestations. The urinalysis revealed proteinuria in 7 patients, proteinuria and hematuria in 3 and proteinuria and glycosuria in 2 patients. All 12 patients with abnormal urinalysis underwent further investigation in order to determine the cause of renal damage and the results are as follows: 2 patients had glomerulonephritis and in other 2 patients renal damage was due to medication adverse effect, 1 had pyelonephritis in combination with chronic active tubulointerstitial nephritis and another 1 had thin basement membrane disease. Three patients had IBD-related dependent renal involvement and 1 resulted in chronic renal failure due to amyloidosis.

Conclusions

It is important for all clinicians to be aware of the possibility of renal manifestations in IBD patients for the early diagnosis and prevention of these manifestations and complications.

背景和研究目的:炎症性肠病的肾脏受累并不常见。本研究旨在描述 IBD 儿童患者肾脏受累的范围,减少发现和治疗的延误:这是一项对所有患者肾功能的回顾性研究,年龄不限:在 75 名 IBD 患者中,16% 有肾脏表现。尿检结果显示,7 名患者出现蛋白尿,3 名患者出现蛋白尿和血尿,2 名患者出现蛋白尿和糖尿。所有 12 名尿检异常的患者都接受了进一步检查,以确定肾损害的原因,结果如下:结果如下:2 名患者患有肾小球肾炎,另外 2 名患者的肾损伤是由药物不良反应引起的,1 名患者患有肾盂肾炎合并慢性活动性肾小管间质性肾炎,另外 1 名患者患有薄基底膜疾病。3名患者有IBD相关的依赖性肾脏受累,1名患者因淀粉样变性导致慢性肾功能衰竭:所有临床医生都必须意识到 IBD 患者出现肾脏表现的可能性,以便及早诊断和预防这些表现及并发症。
{"title":"Renal manifestations in a cohort of pediatric patients with inflammatory bowel disease","authors":"","doi":"10.1016/j.ajg.2024.05.002","DOIUrl":"10.1016/j.ajg.2024.05.002","url":null,"abstract":"<div><h3>Background and study aims</h3><p>Renal involvement in inflammatory bowel disease is rather uncommon. This study aims to describe the spectrum of renal involvement in pediatric patients with IBD and reduce delay in detection and management.</p></div><div><h3>Patients and methods</h3><p>This is a retrospective study of the renal function of all patients, aged &lt;18 years, who have been followed for IBD in our pediatric gastroenterology department from January 2019 till January 2023.</p></div><div><h3>Results</h3><p><span><span>From the 75 IBD patients included in this study 16 % had renal manifestations. The urinalysis revealed </span>proteinuria<span><span> in 7 patients, proteinuria and hematuria<span><span> in 3 and proteinuria and glycosuria<span> in 2 patients. All 12 patients with abnormal urinalysis underwent further investigation in order to determine the cause of renal damage and the results are as follows: 2 patients had glomerulonephritis and in other 2 patients renal damage was due to medication adverse effect, 1 had pyelonephritis<span> in combination with chronic active tubulointerstitial nephritis and another 1 had </span></span></span>thin basement membrane disease. Three patients had IBD-related dependent renal involvement and 1 resulted in </span></span>chronic renal failure due to </span></span>amyloidosis.</p></div><div><h3>Conclusions</h3><p>It is important for all clinicians to be aware of the possibility of renal manifestations in IBD patients for the early diagnosis and prevention of these manifestations and complications.</p></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141735427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pseudomelanosis of the duodenum and stomach 十二指肠和胃假性黑色素瘤。
IF 1.1 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.ajg.2024.02.002

Pseudomelanosis duodeni is characterized by endoscopic findings of black or black-brown speckled pigmentation in the duodenal mucosa, usually diagnosed via biopsy. This report presents a case of a 75-year-old male presented with left lower abdominal pain, change in bowel habits, and decreased appetite. Gastroduodenoscopy and biopsies of the duodenum and antrum lead to the diagnosis of pseudomelanosis duodeni.

假性十二指肠黑变病的特征是内镜下发现十二指肠粘膜有黑色或黑褐色斑点状色素沉着,通常通过活检确诊。本报告介绍了一例 75 岁男性病例,患者出现左下腹疼痛、排便习惯改变和食欲下降。通过胃十二指肠镜检查和十二指肠及肛门活检,确诊为假性十二指肠黑变病。
{"title":"Pseudomelanosis of the duodenum and stomach","authors":"","doi":"10.1016/j.ajg.2024.02.002","DOIUrl":"10.1016/j.ajg.2024.02.002","url":null,"abstract":"<div><p><span>Pseudomelanosis duodeni is characterized by endoscopic findings of black or black-brown speckled pigmentation<span><span> in the duodenal mucosa, usually diagnosed via biopsy. This report presents a case of a 75-year-old male presented with left </span>lower abdominal pain<span><span>, change in bowel habits, and </span>decreased appetite<span>. Gastroduodenoscopy and biopsies of the duodenum and </span></span></span></span>antrum lead to the diagnosis of pseudomelanosis duodeni.</p></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140852528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of biosimilar infliximab in bio-naïve patients with Crohn’s disease 生物仿制药英夫利西单抗在克罗恩病患者中的疗效和安全性。
IF 1.1 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.ajg.2024.03.006

Background and study aims

The infliximab biosimilar CT-P13 was the first biosimilar drug targeting tumor necrosis factor-α. However, its efficacy and safety in real-world clinical situations have remained insufficient. Therefore, we aimed to verify the efficacy and safety of CT-P13 in bio-naïve patients with Crohn’s disease.

Patients and methods

This retrospective multicenter study compared the remission rate at week 54 between patients with Crohn’s disease who were treated with originator infliximab or CT-P13. Endoscopic and laboratory findings were assessed in both groups. A total of 184 (156 originator and 28 CT-P13) patients were analyzed. Of these, 138 originator users and 19 biosimilar users completed 54-week administration.

Results

The clinical remission rates in patients taking originator infliximab of CT-P13 at week 54 were 92.5 % and 100 %, respectively. The endoscopic scores of each group significantly decreased from baseline at week 54 in both groups, and the mucosal healing rate at week 54 was 53 % and 64 %, respectively. Laboratory data including C-reactive protein, serum albumin, and hemoglobin significantly improved from baseline to week 14 and 54 in both groups. Adverse events were observed more frequently in the CT-P13 group (25 % vs. 4.5 %, p = 0.0015), but severe adverse events were rare in both groups.

Conclusion

The efficacy and safety of CT-P13 were comparable with those of originator infliximab in bio-naïve patients with Crohn’s disease evaluated by clinical, endoscopic, and laboratory findings. This study establishes the needed groundwork for the development of a strategy for treatment with biologics in patients with Crohn’s disease.

背景和研究目的:英夫利昔单抗生物仿制药 CT-P13 是首个针对肿瘤坏死因子-α 的生物仿制药。然而,它在实际临床情况下的疗效和安全性仍然不足。因此,我们旨在验证 CT-P13 在克罗恩病患者中的疗效和安全性:这项回顾性多中心研究比较了接受原研英夫利西单抗或CT-P13治疗的克罗恩病患者在第54周时的缓解率。对两组患者的内镜和实验室检查结果进行了评估。共分析了184名患者(156名原研药使用者和28名CT-P13使用者)。其中,138名原研药使用者和19名生物仿制药使用者完成了为期54周的用药:结果:服用原研英夫利西单抗和CT-P13的患者在第54周的临床缓解率分别为92.5%和100%。第54周时,两组患者的内镜评分均较基线明显下降,第54周时的粘膜愈合率分别为53%和64%。从基线到第 14 周和第 54 周,两组的 C 反应蛋白、血清白蛋白和血红蛋白等实验室数据均有明显改善。CT-P13组出现不良反应的频率更高(25%对4.5%,P = 0.0015),但两组均很少出现严重不良反应:结论:通过临床、内镜和实验室检查结果评估,CT-P13 对生物无效的克罗恩病患者的疗效和安全性与原研药英夫利西单抗相当。这项研究为制定克罗恩病患者生物制剂治疗策略奠定了必要的基础。
{"title":"Efficacy and safety of biosimilar infliximab in bio-naïve patients with Crohn’s disease","authors":"","doi":"10.1016/j.ajg.2024.03.006","DOIUrl":"10.1016/j.ajg.2024.03.006","url":null,"abstract":"<div><h3>Background and study aims</h3><p><span><span>The infliximab </span>biosimilar<span> CT-P13 was the first biosimilar </span></span>drug targeting tumor necrosis factor-α. However, its efficacy and safety in real-world clinical situations have remained insufficient. Therefore, we aimed to verify the efficacy and safety of CT-P13 in bio-naïve patients with Crohn’s disease.</p></div><div><h3>Patients and methods</h3><p>This retrospective multicenter study compared the remission rate<span> at week 54 between patients with Crohn’s disease who were treated with originator infliximab or CT-P13. Endoscopic and laboratory findings were assessed in both groups. A total of 184 (156 originator and 28 CT-P13) patients were analyzed. Of these, 138 originator users and 19 biosimilar users completed 54-week administration.</span></p></div><div><h3>Results</h3><p>The clinical remission rates in patients taking originator infliximab of CT-P13 at week 54 were 92.5 % and 100 %, respectively. The endoscopic scores of each group significantly decreased from baseline at week 54 in both groups, and the mucosal healing rate at week 54 was 53 % and 64 %, respectively. Laboratory data including C-reactive protein, serum albumin<span>, and hemoglobin significantly improved from baseline to week 14 and 54 in both groups. Adverse events were observed more frequently in the CT-P13 group (25 % vs. 4.5 %, p = 0.0015), but severe adverse events were rare in both groups.</span></p></div><div><h3>Conclusion</h3><p>The efficacy and safety of CT-P13 were comparable with those of originator infliximab in bio-naïve patients with Crohn’s disease evaluated by clinical, endoscopic, and laboratory findings. This study establishes the needed groundwork for the development of a strategy for treatment with biologics in patients with Crohn’s disease.</p></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140877690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression of the laminin genes family and its relationship to prognosis in pancreatic carcinoma 胰腺癌中层粘蛋白基因家族的表达及其与预后的关系。
IF 1.1 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.ajg.2024.07.006

Background and study aims

Laminin is an extracellular matrix molecule that is the major component of the basement membrane and plays a key role in regulating various processes. However, the association between the laminin gene family and the prognosis of pancreatic carcinoma has not been systematically investigated.

Patients and methods

The role of the laminin gene family in pancreatic cancer was evaluated using data from the TCGA database. The effects of different expressions of members of the laminin gene family on pancreatic cancer survival were compared, and their primary cellular roles were examined. The effects of different expressions of positive family genes on proliferation, metastasis, and invasion, as well as EMT and ferroptosis in pancreatic cancer, were also examined.

Results

Based on univariate and multifactorial analysis of pancreatic cancer patients, LAMA3 was identified as an independent prognostic factor for overall survival in pancreatic cancer. LAMA3 was found to be enriched in the actin cytoskeleton, P53 signaling pathway, adhesion molecule junctions, pentose phosphate pathway, and regulatory differences in the cell cycle and focal adhesion. Additionally, high expression of LAMA3 was found to promote cancer proliferation, invasion, and metastasis, facilitate the EMT process, and inhibit ferroptosis.

Conclusions

Our results identified LAMA3 was associated with the prognosis of patients with pancreatic cancer and may serve as a prognostic biomarker for pancreatic cancer.

背景和研究目的:层粘连蛋白是一种细胞外基质分子,是基底膜的主要成分,在调节各种过程中发挥着关键作用。然而,层粘连蛋白基因家族与胰腺癌预后之间的关联尚未得到系统研究:利用 TCGA 数据库的数据评估了层粘连蛋白基因家族在胰腺癌中的作用。比较了层粘连蛋白基因家族成员的不同表达对胰腺癌生存率的影响,并研究了它们的主要细胞作用。此外,还研究了阳性家族基因的不同表达对胰腺癌的增殖、转移和侵袭以及EMT和铁变态反应的影响:结果:基于对胰腺癌患者的单变量和多因素分析,LAMA3被确定为胰腺癌总生存期的独立预后因素。研究发现,LAMA3富集于肌动蛋白细胞骨架、P53信号通路、粘附分子连接、磷酸戊糖通路以及细胞周期和病灶粘附的调控差异中。此外,研究还发现 LAMA3 的高表达可促进癌症的增殖、侵袭和转移,促进 EMT 过程,并抑制铁凋亡:我们的研究结果表明,LAMA3 与胰腺癌患者的预后有关,可作为胰腺癌的预后生物标志物。
{"title":"Expression of the laminin genes family and its relationship to prognosis in pancreatic carcinoma","authors":"","doi":"10.1016/j.ajg.2024.07.006","DOIUrl":"10.1016/j.ajg.2024.07.006","url":null,"abstract":"<div><h3>Background and study aims</h3><p>Laminin is an extracellular matrix molecule that is the major component of the basement membrane and plays a key role in regulating various processes. However, the association between the laminin gene family and the prognosis of pancreatic carcinoma has not been systematically investigated.</p></div><div><h3>Patients and methods</h3><p>The role of the laminin gene family in pancreatic cancer was evaluated using data from the TCGA database. The effects of different expressions of members of the laminin gene family on pancreatic cancer survival were compared, and their primary cellular roles were examined. The effects of different expressions of positive family genes on proliferation, metastasis, and invasion, as well as EMT and ferroptosis in pancreatic cancer, were also examined.</p></div><div><h3>Results</h3><p>Based on univariate and multifactorial analysis of pancreatic cancer patients, LAMA3 was identified as an independent prognostic factor for overall survival in pancreatic cancer. LAMA3 was found to be enriched in the actin cytoskeleton, P53 signaling pathway, adhesion molecule junctions, pentose phosphate pathway, and regulatory differences in the cell cycle and focal adhesion. Additionally, high expression of LAMA3 was found to promote cancer proliferation, invasion, and metastasis, facilitate the EMT process, and inhibit ferroptosis.</p></div><div><h3>Conclusions</h3><p>Our results identified LAMA3 was associated with the prognosis of patients with pancreatic cancer and may serve as a prognostic biomarker for pancreatic cancer.</p></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1687197924000686/pdfft?md5=ff180492a3408579551251fa9ef12d85&pid=1-s2.0-S1687197924000686-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141749335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arab Journal of Gastroenterology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1